Health Outcomes of Severely Obese Type 2 Diabetic Subjects 1 Year After Laparoscopic Adjustable Gastric Banding
- John B. Dixon, MBBS1 and
- Paul E. O’Brien, MD1
Abstract
OBJECTIVE—To prospectively examine the effect of weight loss 1 year after laparoscopic adjustable gastric band surgery on a broad range of health outcomes in 50 diabetic subjects.
RESEARCH DESIGN AND METHODS—A total of 50 (17 men, 33 women) of 51 patients with type 2 diabetes, from a total of 500 consecutive patients, were studied preoperatively and again 1 year after surgery.
RESULTS—Preoperative weight and BMI (means ± SD) were 137 ± 30 kg and 48.2 ± 8 kg/m2, respectively; at 1 year, weight and BMI were 110 ± 24 kg and 38.7 ± 6 kg/m2, respectively. There was significant improvement in all measures of glucose metabolism. Remission of diabetes occurred in 32 patients (64%), and major improvement of glucose control occurred in 13 patients (26%); glucose metabolism was unchanged in 5 patients (10%). HbA1c was 7.8 ± 3.2% preoperatively and 6.2 ± 2.7% at 1 year (P < 0.001). Remission of diabetes was predicted by greater weight loss and a shorter history of diabetes (pseudo r2 = 0.44, P < 0.001). Improvement in diabetes was related to increased insulin sensitivity and β-cell function. Weight loss was associated with significant improvements in fasting triglyceride level, HDL cholesterol level, hypertension, sleep, depression, appearance evaluation, and health-related quality of life. Early complications occurred in 6% of patients (wound infections in 4%, respiratory support in 2%), and late complications occurred in 30% of patients (gastric prolapse in 20%, band erosion in 6%, and tubing leaks in 4%). All late complications were successfully revised surgically.
CONCLUSIONS—Modern laparoscopic weight-loss surgery is effective in managing the broad range of health problems experienced by severely obese individuals with type 2 diabetes. Surgery should be considered as an early intervention.
- %EWL, percentage of excess weight loss
- %EWL1, %EWL at 1 year
- HOMA, homeostasis model assessment
- HUMA%B, percentage of β-islet cell function assessed by HOMA
- HOMA%S, percentage of insulin sensitivy assessed by HOMA
- LAGB, laparoscopically placed adjustable gastric band
- pr2, pseudo r2
Footnotes
-
Address correspondence and reprint requests to Dr. John Dixon, Monash University Department of Surgery, Alfred Hospital, Melbourne 3181, Australia. E-mail: john.dixon{at}med.monash.edu.au.
Received for publication 9 May 2001 and accepted in revised form 17 October 2001.
A table elsewhere in this issue shows conventional and Système International (SI) units and conversion factors for many substances.











